Different Doses of Nebulized Magnesium Sulphate in Status Asthmaticus

Status Completed

Clinical Trial Summary

In this study investigators will use magnesium sulphate in the nebulized form in children between 2 and 12 years of age as an acute reliever for acute severe asthma. Aim of this study is to determine that whether adding low (250mg), intermediate (500mg), and high doses (750mg) of magnesium sulphate in the 1st hour of treatment has any difference in the improvement of clinical condition of the patient and length of hospital stay. There will be total 108 patients having 2 groups. 1st group will receive only Ventolin while 2nd group will be given Ventolin and Magnesium sulphate.

Clinical Trial Description

This randomized clinical trial will include 126 patients after taking informed consent who will meet the eligibility criteria. Patients will be randomly distributed in 2 groups on alternate basis as computerized generated number. Improvement will be assessed in terms of clinical condition i.e., Heart Rate, Respiratory Rate, blood pressure, pattern of breathing oxygen saturation and Pediatric Respiratory Assessment Measure (PRAM) score at start of treatment and then afterwards at 20 min interval up to 1 hour and then at 2nd hour and then after every 6 hours for 24 hours. ;

Study Design

Related Conditions & MeSH terms

Status Asthmaticus

Clinical Trial Details

NCT number	NCT04929626
Study type	Interventional
Source	Ziauddin University
Contact
Status	Completed
Phase	Phase 1
Start date	January 1, 2022
Completion date	November 12, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02872597` - Phase I, Placebo-Controlled, Blinded Pilot Study of Ipratropium in Children Admitted to the ICU With Status Asthmaticus	Phase 1
Terminated	`NCT02966184` - Comparison of Albuterol for Status Asthmaticus	Phase 4
Enrolling by invitation	`NCT00750568` - Intravenous Terbutaline in Severe Status Asthmaticus	N/A
Completed	`NCT00124995` - Trial of Terbutaline for the Treatment of Status Asthmaticus in Children	Phase 4
Recruiting	`NCT05819541` - Treating Exacerbations of Asthma With Oral Montelukast in Children	Phase 2
Completed	`NCT01524198` - The Use of Inhaled Corticosteroids in the Treatment of Asthma is Children in the Emergency Room	Phase 2/Phase 3
Terminated	`NCT02780479` - Steroids in Children Hospitalized With Asthma	Phase 4
Withdrawn	`NCT01403428` - Non Invasive Positive Pressure Ventilation in Status Asthmaticus	Phase 2
Terminated	`NCT00683449` - Study Evaluating the Safety and Effects of MN-221 in Subjects Experiencing an Acute Exacerbation of Asthma	Phase 2
Withdrawn	`NCT03219736` - NiPPV in the Treatment of Acute Asthma Exacerbations	N/A
Completed	`NCT00722020` - HFCWO in Hospitalized Asthmatic Children	N/A
Withdrawn	`NCT03338205` - The Role of Ketamine as an Adjuvant Therapy for Children With Acute Status Asthmaticus	Phase 3
Completed	`NCT02302261` - Pleth Variability and Asthma Severity in Children	N/A
Recruiting	`NCT01770899` - Evaluation Montelukast in the Treatment of Status Asthmaticus	N/A
Withdrawn	`NCT01188473` - Early Noninvasive Positive Pressure Ventilation in Children With Status Asthmaticus	Phase 1
Withdrawn	`NCT04656587` - BPAP in Pediatric Asthma Pilot Study	N/A
Completed	`NCT00623688` - Effectiveness and Cost Study Comparing Two Ways to Deliver Albuterol for the Treatment of Asthma in the Hospital	N/A
Recruiting	`NCT00491790` - Montelukast With Status Asthmaticus, Ages 2-5	Phase 2/Phase 3
Recruiting	`NCT00494572` - Montelukast With Status Asthmaticus, Ages 6-18	Phase 2/Phase 3
Completed	`NCT00279786` - B2-Adrenergic Receptor Polymorphisms